These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10750250)

  • 1. Anticoagulation and the cardioversion of atrial flutter.
    James PR; Hardman SM
    Int J Clin Pract; 2000; 54(1):5-6. PubMed ID: 10750250
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
    Densèm CG
    Am J Cardiol; 1999 Jan; 83(1):140-1. PubMed ID: 10073808
    [No Abstract]   [Full Text] [Related]  

  • 3. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography.
    Mehta D; Baruch L
    Chest; 1996 Oct; 110(4):1001-3. PubMed ID: 8874259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
    Bertaglia E; D'Este D; Franceschi M; Pascotto P
    Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic anticoagulation of atrial flutter prior to cardioversion: meeting the "burden of proof".
    Silverman DI; Manning WJ
    Am J Med; 2001 Oct; 111(6):493-4. PubMed ID: 11690577
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for anticoagulation prior to cardioversion.
    Coleman MT
    Am Fam Physician; 1995 Aug; 52(2):387-8. PubMed ID: 7503866
    [No Abstract]   [Full Text] [Related]  

  • 8. Subtherapeutic anticoagulation: the bane of conventional anticoagulation for cardioversion of atrial fibrillation.
    Sallach JA; Klein AL
    Eur J Echocardiogr; 2004 Aug; 5(4):239-42. PubMed ID: 15219536
    [No Abstract]   [Full Text] [Related]  

  • 9. The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem.
    Stellbrink C; Hanrath P
    Eur Heart J; 2000 May; 21(10):795-8. PubMed ID: 10781349
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complications.
    Guo H; Shaheen W; Kerber R; Olshansky B
    Prog Cardiovasc Dis; 2004; 46(6):487-505. PubMed ID: 15224256
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of electrical cardioversion in patients with previous embolic events.
    Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
    Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter.
    Yadlapati A; Groh C; Passman R
    Am J Cardiol; 2014 Apr; 113(8):1362-3. PubMed ID: 24576547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
    Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
    Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolism in chronic atrial flutter: is the risk underestimated?
    Lanzarotti CJ; Olshansky B
    J Am Coll Cardiol; 1997 Nov; 30(6):1506-11. PubMed ID: 9362409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Grimm RA
    Echocardiography; 2000 May; 17(4):383-92. PubMed ID: 10979011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock following electro-cardioversion of new onset atrial flutter.
    Khan MU; Khouzam RN; Khalid H; Baqir R; Moten M
    Heart Lung; 2013; 42(6):462-4. PubMed ID: 23969007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioversion of atrial fibrillation or flutter: a 'stunning' problem.
    Kamath S; Lip GY
    Eur Heart J; 2001 Mar; 22(6):520-1. PubMed ID: 11237547
    [No Abstract]   [Full Text] [Related]  

  • 20. Periprocedural Anticoagulation for Cardioversion of Acute Onset Atrial Fibrillation and Flutter: Evidence Base for Current Guidelines.
    Andrade JG; Mitchell LB
    Can J Cardiol; 2019 Oct; 35(10):1301-1310. PubMed ID: 31601412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.